Page last updated: 2024-12-07

cyfluthrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyfluthrin: effective against mosquitoes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyfluthrin : A carboxylic ester obtained by formal condensation between 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid and (4-fluoro-3-phenoxyphenyl)(hydroxy)acetonitrile. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

cethromycin: a ketolide; [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cethromycin : A macrolide antibiotic which displays in vitro activity against both gram-positive and gram-negative bacteria and is currently under investigation for the treatment of community-acquired pneumonia. The US Food and Drug Administration (FDA) have also granted orphan drug designation to cethromycin for the treatment of anthrax prophylaxis, tularemia, and plague (PDB entry: 1NWX). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID104926
CHEMBL ID2104608
CHEBI ID4034
SCHEMBL ID26024
MeSH IDM0149164
PubMed CID447451
CHEMBL ID133924
CHEBI ID29506
SCHEMBL ID1818083
MeSH IDM0149164

Synonyms (114)

Synonym
cyfluthrin [bsi:iso]
(1rs,3sr)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
ai3-29604
alpha-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
caswell no. 266e
brn 2788149
tempo 2
cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethyl-cyclopropanecarboxylate
3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, cyano(4-fluoro-3-phenoxyphenyl)methyl ester
(rs)-alpha-cyano-4-fluoro-3-phenoxybenzyl (1rs,3rs:1rs,3sr)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
fcr 1272
bay-fcr 1272
bay fcr 1272
(rs)-alpha-cyano-4-fluoro-3-phenoxybenzyl (1rs,3rs; 1rs,3sr)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
bay-vi 1704
syfrutrin
cyfluthine [iso-french]
einecs 269-855-7
hsdb 6599
cyfluthrine
epa pesticide chemical code 128831
cyfluthrin [ban]
responsar
cyfoxylate
3-(2,2-dichloroethenyl)-2,2-diethylcyclopropanecarboxylic acid cyano(4-fluoro-3-phenoxyphenyl)methyl ester
cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, cyano(4-fluoro-3-phenoxyphenyl)methyl ester
cyclopropanecarboxylic acid, 2-(2,2-dichlorovinyl)-3,3-dimethyl-, ester with (4-fluoro-3-phenoxyphenyl)hydroxyacetonitrile
solfac
fcr 4545
eulan sp
baythroid h
cylence (tn)
D07761
cyfluthrin (ban)
cyfluthrin
68359-37-5
(r,s)-alpha-cyano-4-fluoro-3-phenoxybenzyl-(1r,s)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
CHEBI:4034 ,
cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
baythroid
bulldock
[cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate
bay vl 1704
unii-scm2qlz6s0
cyfluthine
scm2qlz6s0 ,
ccris 9269
tox21_300645
NCGC00254553-01
cas-68359-37-5
dtxcid6028078
dtxsid5035957 ,
CHEMBL2104608
bay-vl-1704
fcr-1272
[cyano-(4-fluoro-3-phenoxy-phenyl)methyl] 3-(2,2-dichlorovinyl)-2,2-dimethyl-cyclopropanecarboxylate
FT-0641182
cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
AKOS015899750
cyfluthrin [hsdb]
cyfluthrin [mart.]
cyfluthrin [mi]
cyfluthrin [iso]
3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid cyano(4-fluoro-3-phenoxyphenyl)methyl ester
(rs)-.alpha.-cyano-4-fluoro-3-phenoxybenzyl (1rs,3rs; 1rs,3sr)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
(r,s)-.alpha.-cyano-4-fluoro-3-phenoxybenzyl-(1r,s)-cis,trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate
cyfluthrin [jan]
SCHEMBL26024
KS-5075
baythroid 2 (salt/mix)
sofac
cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate #
QQODLKZGRKWIFG-UHFFFAOYSA-N
.beta.-cyfluthrin
baytroid (salt/mix)
sr-01000883726
SR-01000883726-1
beta-cyfluthrin, pestanal(r), analytical standard
baythroid(r), pestanal(r), analytical standard
cyfluthrin 10 microg/ml in cyclohexane
cyfluthrin 100 microg/ml in cyclohexane
BCP19177
DB13828
mfcd00078636
cyfluthrin 1000 microg/ml in acetone
CS-0013907
AMY3612
HY-B1837
3-nitro-4-methoxybenzylsulfonylaceticacid
beta-cyfluthrin solution
restanza
a-195773.0
205110-48-1
cethromycin
D02391
cethromycin [usan]
CHEMBL133924
j0086219x6 ,
cethromycin [mi]
cethromycin [who-dd]
cethromycin [inn]
cethromycin [mart.]
cetromicina
cethromycine
CHEBI:29506
(3as,4r,7r,9r,10r,11r,13r,15r,15ar)-4-ethyl-3a,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxo-11-{[3-(quinolin-3-yl)prop-2-en-1-yl]oxy}tetradecahydro-2h-oxacyclotetradecino[4,3-d][1,3]oxazol-10-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranoside
cethromycinum
SCHEMBL1818083
DB06419
(3as,4r,7r,9r,10r,11r,13r,15r,15ar)-4-ethyl-3a,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxo-11-{[(2e)-3-quinolin-3-ylprop-2-en-1-yl]oxy}tetradecahydro-2h-oxacyclotetradecino[4,3-d][1,3]oxazol-10-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-d-xylo-hexopyranoside
gtpl10791
(1s,2r,5r,7r,8r,9r,11r,13r,14r)-8-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-9-[(e)-3-quinolin-3-ylprop-2-enoxy]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone
abt773
bdbm50511979

Research Excerpts

Overview

Cyfluthrin is a pyrethroid insecticide and common household pesticide. Beta-cy Fluthrin (CYF) is a commonly used synthetic pyrethroin having both agricultural and domestic applications.

ExcerptReferenceRelevance
"Cyfluthrin is a widely used pesticide. "( Effective preparation of magnetic molecularly imprinted polymer nanoparticle for the rapid and selective extraction of cyfluthrin from honeysuckle.
Chen, Y; Hu, X; Xie, Z; Zhang, L, 2020
)
2.21
"Cyfluthrin is a pyrethroid insecticide and common household pesticide. "( Action of the insecticide cyfluthrin on Ca
Chou, CT; Hao, LJ; Jan, CR; Kuo, CC; Liang, WZ; Lu, YC, 2020
)
2.3
"Cyfluthrin is a synthetic pyrethroid used worldwide to protect crops and to eliminate pests."( The effects of cyfluthrin on some biomarkers in the liver and kidney of Wistar rats.
Canli, M; Rencuzogullari, E; Yilmaz, M, 2015
)
1.49
"Beta-cyfluthrin (CYF) is a commonly used synthetic pyrethroid having both agricultural and domestic applications. "( Beta-cyfluthrin induced neurobehavioral impairments in adult rats.
Chandravanshi, LP; Khanna, VK; Soni, I; Syed, F, 2016
)
1.46
"beta-cyfluthrin is a good insecticide for mosquito control."( Beta-cyfluthrin, a synthetic pyrethroid for mosquito control.
Rajavel, AR; Vasuki, V, 1992
)
1.25

Treatment

Cyfluthrin-treated rats (1, 5 and 10mg/kg bw, orally 6 days), had no visible injury, i.e., no clinical signs of dysfunction were observed. Cyfluthin-treated nets were mildly irritating to host-seeking female anophelines in the laboratory.

ExcerptReferenceRelevance
"Beta-cyfluthrin-treated inserts were able to kill 51% of resistant Cx."( Efficacy of a 'lethal house lure' against Culex quinquefasciatus from Bouaké city, Côte d'Ivoire.
Ahoua Alou, LP; Barreaux, AMG; Camara, S; Dahounto, A; Koffi, AA; N'Guessan, R; Oumbouke, WA; Sternberg, ED; Thomas, MB; Tia, IZ; Wolie, RZ; Yapi, GY, 2023
)
1.37
"Cyfluthrin-treated rats (1, 5 and 10mg/kg bw, orally 6 days), had no visible injury, i.e., no clinical signs of dysfunction were observed."( Effects of exposure to pyrethroid cyfluthrin on serotonin and dopamine levels in brain regions of male rats.
Anadón, A; Ares, I; Castellano, V; Martínez, M; Martínez, MA; Martínez-Larrañaga, MR; Rodríguez, JL, 2016
)
1.43
"Cyfluthrin-treated nets were mildly irritating to host-seeking female anophelines in the laboratory."( Cyfluthrin (EW 050)-impregnated bednets in a malaria control program in Ghassreghand (Baluchistan, Iran).
Edrissian, GH; Ghavami, MB; Nateghpour, M; Nazari, M; Zaim, M, 1998
)
2.46
"Cyfluthrin treated female mosquitoes showed reduced fecundity rates in An."( Evaluation of cyfluthrin and fenfluthrin for their insecticidal activity against three vector mosquitoes.
Dash, AP; Mohapatra, R; Ranjit, MR, 1999
)
1.39

Toxicity

Cyfluthrin (β-CYF) induced oxidative stress, genotoxicity, histopathological alterations and the role of curcumin (CUR) in alleviating its toxic effects. It seems that trans-FA could ameliorate toxic effect of β-cy Fluthrin via reduction of peroxidative and nitrosative reactions over cold preservation of rooster semen.

ExcerptReferenceRelevance
" In cis-bifenthrin (cis-BF) and cis-permethrin (cis-PM), the 1R-cis isomer was 15-38 times more active than the 1S-cis enantiomer, while in trans-PM, the 1R-trans isomer was substantially more toxic than the 1S-trans enantiomer."( Separation and aquatic toxicity of enantiomers of synthetic pyrethroid insecticides.
Gan, JJ; Liu, W; Qin, S, 2005
)
0.33
" The results obtained indicate the need for additional studies on the genotoxicity of these substances and their adverse effects on human health."( Genotoxic effects of pentachlorophenol, lindane, transfluthrin, cyfluthrin, and natural pyrethrum on human mucosal cells of the inferior and middle nasal conchae.
Faulde, MK; Maier, H; Tisch, M,
)
0.37
"Use of pyrethroid pesticides, which are highly toxic to aquatic organisms, has increased substantially over the past decade."( Toxicity of a dissolved pyrethroid mixture to Hyalella azteca at environmentally relevant concentrations.
Brander, SM; Deanovic, LA; Werner, I; White, JW, 2009
)
0.35
") fingerlings in order to investigate the adverse effects of a sublethal concentration of 10 microg/L cyfluthrin for 48h and one week using the semi-static test system."( Sublethal cyfluthrin toxicity to carp (Cyprinus carpio L.) fingerlings: biochemical, hematological, histopathological alterations.
Ayhan Ozkul, I; Cağlan Karasu Benli, A; Erkoç, F; Sahin, D; Sarikaya, R; Selvi, M; Sepici-Dinçel, A, 2009
)
0.97
"This study was designed to investigate the possibility of β-cyfluthrin to induce oxidative stress and biochemical perturbations in rat liver and the role of selenium in alleviating its toxic effects."( Selenium modulates β-cyfluthrin-induced liver oxidative toxicity in rats.
El-Demerdash, FM; Jebur, AB; Nasr, HM, 2014
)
0.96
" Although this patient experienced a benign clinical course, vigilance for pyrethroid toxic effects such as seizures, severe tremors, diaphoresis, and choreoathetosis is paramount."( Human intravenous injection of β-cyfluthrin with minimal toxic effects.
Menowsky, M; Miller, MA, 2014
)
0.68
" Pyrethroids were more toxic than the organophosphate chlorpyrifos in both species."( A comparison of the sublethal and lethal toxicity of four pesticides in Hyalella azteca and Chironomus dilutus.
Connon, RE; Geist, J; Hasenbein, S; Lawler, SP, 2015
)
0.42
"Present study examines the possibility of β-cyfluthrin (β-CYF) induced oxidative stress, genotoxicity, histopathological alterations and the role of curcumin (CUR) in alleviating its toxic effects."( Curcumin modulates oxidative stress and genotoxicity induced by a type II fluorinated pyrethroid, beta-cyfluthrin.
Awasthi, KK; John, PJ; Rajawat, NK; Soni, I; Verma, R, 2016
)
0.91
" promelas larvae to a nontoxic dose of phostebupirim and a range of toxic cyfluthrin concentrations, and vice versa."( Mixture toxicity of phostebupirim and cyfluthrin: Species-specific responses.
de Perre, C; Lydy, MJ; Murphy, TM, 2017
)
0.96
" It seems that trans-FA could ameliorate toxic effect of β-cyfluthrin via reduction of peroxidative (as evident by measurement of MDA) and nitrosative (as evident by measurement of nitrate-nitrite) reactions over cold preservation of rooster semen."( Ameliorative role of trans-ferulic acid on induced oxidative toxicity of rooster semen by β-cyfluthrin during low temperature liquid storage.
Eslami, M; Ghaniei, A; Shayan-Nasr, M; Zadeh-Hashem, E, 2021
)
1.08
" No clinically significant adverse events were observed during the studies."( Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies.
Eiznhamer, DA; English, ML; Flavin, MT; Fredericks, CE; Jenta, TR; Milanesio, NA; Rohowsky, N; Xu, ZQ, 2012
)
0.38

Pharmacokinetics

ExcerptReferenceRelevance
"To address concerns around age-related sensitivity to pyrethroids, a life-stage physiologically based pharmacokinetic (PBPK) model, supported by in vitro to in vivo extrapolation (IVIVE) was developed."( Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.
Clewell, HJ; Creek, MR; Efremenko, AY; Hinderliter, P; Hines, RN; Lake, BG; Mallick, P; Moreau, M; Osimitz, TG; Pendse, SN; Song, G; Yoon, M, 2020
)
0.56
" Population pharmacokinetic analysis was performed using the NONMEM computer program."( Pharmacokinetics of ABT-773, a new semi-synthetic ketolide in neutropenic lung-infected mice: a population approach.
Kim, M; Nicolau, DP; Nightingale, CH; Xuan, D; Ye, M, 2002
)
0.31
" pneumoniae in a murine pneumonia model and to describe the pharmacodynamic (PD) profile of cethromycin."( Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
Kim, MK; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W, 2002
)
0.31
"The objective of this study was to determine the steady-state plasma and intrapulmonary pharmacokinetic parameters of orally administered cethromycin in healthy volunteers."( Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
Conte, JE; Golden, JA; Kipps, J; Zurlinden, E, 2004
)
0.32

Bioavailability

ExcerptReferenceRelevance
" Limited data have shown that DOM preparations can significantly alter the bioavailability and toxicity effects of pyrethroids."( Bioavailability of permethrin and cyfluthrin in surface waters with low levels of dissolved organic matter.
Gan, J; Hunter, W; Spurlock, F; Yang, WC,
)
0.41
" Consideration of bioavailability increasingly requires the measurement of freely dissolved concentration (Cfree) in addition to the total chemical concentration (Ctotal)."( Simultaneous measurement of free and total concentrations of hydrophobic compounds.
Bondarenko, S; Gan, J, 2009
)
0.35
" The bioavailability of ABT-773 in humans is unaffected by food [383228] and in a phase I, randomized, double-blind trial in healthy males only mild adverse effects, usually affecting the gastrointestinal system, were observed [383208]."( ABT-773 (Abbott Laboratories).
Lawrence, LE, 2001
)
0.31
" Sucralfate had no impact on the bioavailability of ABT-773."( ABT-773: pharmacokinetics and interactions with ranitidine and sucralfate.
Allewelt, M; Bulitta, J; Burkhardt, O; Lode, H; Pletz, MW; Preechachatchaval, V, 2003
)
0.32
" Combined with an advantageous pharmacokinetic profile (good oral bioavailability and penetration in the respiratory tract tissues and fluids; prolonged half-life allowing for once-a-day administration), these antimicrobial properties make ketolides an attractive alternative for the treatment of severe respiratory tract infections such as pneumonia in areas with significant resistance to conventional macrolides."( Ketolides: pharmacological profile and rational positioning in the treatment of respiratory tract infections.
Harms, JM; Tulkens, PM; Van Bambeke, F; Van Laethem, Y, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" Two dosage schedules; 2 rounds of indoor residual sparying a year, at 25 mg/sq."( Field trial of cyfluthrin as an effective and safe insecticide for control of malaria vectors in triple insecticide resistant areas.
Biswas, H; Rao, CK; Yadava, RL, 1996
)
0.65
" The collection, impregnation (target dosage of 40 mg active ingredient [AI]/m2), and redistribution of the nets (9% nylon, 52% light cotton, 30% medium cotton, and 9% heavy cotton), carried out in mid-April, were done by local health workers, supervised by the senior research staff."( Cyfluthrin (EW 050)-impregnated bednets in a malaria control program in Ghassreghand (Baluchistan, Iran).
Edrissian, GH; Ghavami, MB; Nateghpour, M; Nazari, M; Zaim, M, 1998
)
1.74
" cornicina were exposed to dung collected from calves dosed with topical preparations of deltamethrin, flumethrin, cyfluthrin, and alpha-cypermethrin."( Topical treatment of calves with synthetic pyrethroids: effects on the non-target dung fly Neomyia cornicina (Diptera: Muscidae).
Jespersen, JB; Sommer, C; Vagn Jensen, KM, 2001
)
0.52
"Estimations of absorbed daily dosage (ADD) of chemicals following contact with treated surfaces may be required for risk assessment and risk management."( Human exposure to indoor residential cyfluthrin residues during a structured activity program.
Bernard, CE; Krieger, RI; Williams, RL, 2003
)
0.59
" Following the free of charge treatment of the adult cattle at intervals of 7 weeks and at a dosage of 15 ml/100 kg body weight, there was an increase in the average packed cell volume in the herd although the decline in the incidence of trypanosomal infections was more prolonged."( A large-scale trial to evaluate the efficacy of a 1% pour-on formulation of cyfluthrin (Cylence, Bayer) in controlling bovine trypanosomosis in Eastern Zambia.
Jooste, R; Lumamba, D; Mubanga, J; Munsimbwe, L; Van den Bossche, P, 2004
)
0.55
"Veterinary and medical entomologists who are involved in research on pest control often need to perform dose-response bioassays and analyze the results."( Oral and Topical Insecticide Response Bioassays and Associated Statistical Analyses Used Commonly in Veterinary and Medical Entomology.
Burgess, ER; Geden, CJ; King, BH, 2020
)
0.56
" This impairs survival after exposure to BC at it has a negative temperature coefficient, derived from a dysfunction of the central nervous system regarding thermoregulation caused by the high dosage of neurotoxicant and resulting temperature maladaptation."( Thermoregulation of Eremias argus alters temperature-dependent toxicity of beta-cyfluthrin: Ecotoxicological effects considering ectotherm behavior traits.
Deng, Y; Diao, J; Liu, R; Nie, Y; Wang, Z; Yu, S; Zhang, L; Zhou, Z; Zhu, W, 2022
)
0.95
"03) and on the fifth day of twice-daily dosing (12."( CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels.
Bukofzer, S; Cassar, SC; Driscoll, RM; Gentile, MC; Gordon, EF; Grimm, DR; Gustavson, LE; Katz, DA; O'dea, RF; Polzin, JE; Rieser, MJ; Williams, LA; Ye, X, 2004
)
0.32
" C(max)/90% minimum inhibitory concentration (MIC(90)) ratios, area under the concentration-time curve (AUC)/MIC(90) ratios, intrapulmonary drug exposure ratios, and percent time above MIC(90) during the dosing interval (%T > MIC(90)) were calculated for recently reported respiratory pathogens."( Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin.
Conte, JE; Golden, JA; Kipps, J; Zurlinden, E, 2004
)
0.32
" Factors such as overprescribing of antibiotics and noncompliance with dosing regimens have added to the growing antibacterial resistance problem."( Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies.
Eiznhamer, DA; English, ML; Flavin, MT; Fredericks, CE; Jenta, TR; Milanesio, NA; Rohowsky, N; Xu, ZQ, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
pyrethroid ester insecticidenull
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
cyclopropanecarboxylate esterA carboxylic ester resulting from the formal condensation of the hydroxy group of an alcohol or phenol with the carboxy group of cyclopropanecarboxylic acid or its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency54.94103.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency5.27170.006038.004119,952.5996AID1159521; AID1159523
AR proteinHomo sapiens (human)Potency21.87240.000221.22318,912.5098AID743063
progesterone receptorHomo sapiens (human)Potency13.68540.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency48.96620.000214.376460.0339AID720691
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency54.48270.001530.607315,848.9004AID1224848; AID1224849; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency19.49380.375827.485161.6524AID743217
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency61.64480.001019.414170.9645AID743094
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency34.66540.023723.228263.5986AID743223
aryl hydrocarbon receptorHomo sapiens (human)Potency5.44830.000723.06741,258.9301AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency6.85900.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency3.43760.001628.015177.1139AID1224843
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency42.842919.739145.978464.9432AID1159509; AID1159518
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency24.54120.057821.109761.2679AID1159526
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency37.01780.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency54.94100.042027.378961.6448AID743210
Cellular tumor antigen p53Homo sapiens (human)Potency76.95880.002319.595674.0614AID651631
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (124)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (19)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (47)

Assay IDTitleYearJournalArticle
AID1111367Insecticidal activity against Phthorimaea operculella assessed as mortality at 0.35 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111364Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111344Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 8 days by cage bio assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111372Insecticidal activity against Phthorimaea operculella assessed as mortality at 2.5 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111345Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 6 days by cage bio assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111369Insecticidal activity against Phthorimaea operculella assessed as mortality at 0.65 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111361Insecticidal activity against Symmetrischema tangolias assessed as mortality at 1.25 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111349Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 4 days by attract-and-kill assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111354Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 24 hr by attract-and-kill assay2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111374Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111347Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 36 days by cage bio assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111355Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 4 days by attract-and-kill assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111352Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 24 hr by attract-and-kill assay2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111363Insecticidal activity against Symmetrischema tangolias assessed as mortality at 2.5 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111360Insecticidal activity against Symmetrischema tangolias assessed as mortality at 1.25 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111358Insecticidal activity against Symmetrischema tangolias assessed as mortality at 0.65 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111368Insecticidal activity against Phthorimaea operculella assessed as mortality at 0.65 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111350Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 24 hr by attract-and-kill assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111375Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1112034Insecticidal activity against Drosophila suzukii assessed as mortality at 24 g/ha by direct application at 22 degC measured after 24 hr2011Pest management science, Nov, Volume: 67, Issue:11
Laboratory and field comparisons of insecticides to reduce infestation of Drosophila suzukii in berry crops.
AID1111371Insecticidal activity against Phthorimaea operculella assessed as mortality at 1.25 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111351Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 24 hr by attract-and-kill assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111359Insecticidal activity against Symmetrischema tangolias assessed as mortality at 0.65 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111373Insecticidal activity against Phthorimaea operculella assessed as mortality at 2.5 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111348Insecticidal activity against Phthorimaea operculella assessed as mortality at 5 g/l after 3 days by cage bio assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111370Insecticidal activity against Phthorimaea operculella assessed as mortality at 1.25 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111357Insecticidal activity against Symmetrischema tangolias assessed as mortality at 0.35 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111362Insecticidal activity against Symmetrischema tangolias assessed as mortality at 2.5 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111356Insecticidal activity against Symmetrischema tangolias assessed as mortality at 0.35 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111366Insecticidal activity against Phthorimaea operculella assessed as mortality at 0.35 g/l after 48 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111346Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 36 days by cage bio assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111365Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 24 hr2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1111353Insecticidal activity against Symmetrischema tangolias assessed as mortality at 5 g/l after 3 days by cage bio assay relative to control2010Pest management science, May, Volume: 66, Issue:5
Attract-and-kill: a new strategy for the management of the potato tuber moths Phthorimaea operculella (Zeller) and Symmetrischema tangolias (Gyen) in potato: laboratory experiments towards optimising pheromone and insecticide concentration.
AID1646213Protein binding in plasma (unknown origin)2020Journal of medicinal chemistry, 06-25, Volume: 63, Issue:12
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
AID1278832Antibacterial activity against Haemophilus influenzae by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278826Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B resistant Streptococcus pneumoniae by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278823Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B resistant Staphylococcus aureus by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278833Antibacterial activity against Moraxella catarrhalis by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278831Antibacterial activity against efflux mediated macrolide resistant Streptococcus pyogenes by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278830Antibacterial activity against constitutive macrolide-lincosamide-streptogramin B resistant Streptococcus pyogenes by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278825Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278824Antibacterial activity against efflux mediated macrolide resistant Staphylococcus aureus by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278827Antibacterial activity against efflux mediated macrolide resistant Streptococcus pneumoniae by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278828Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278822Antibacterial activity against inducibly macrolide-lincosamide-streptogramin B resistant Staphylococcus aureus by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278829Antibacterial activity against inducibly macrolide-lincosamide-streptogramin B resistant Streptococcus pyogenes by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
AID1278821Antibacterial activity against erythromycin-susceptible Staphylococcus aureus by agar microdilution method2016Bioorganic & medicinal chemistry, Mar-15, Volume: 24, Issue:6
Synthesis and antibacterial evaluation of novel 4″-glycyl linked quinolyl-azithromycins with potent activity against macrolide-resistant pathogens.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (374)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (1.07)18.7374
1990's37 (9.89)18.2507
2000's175 (46.79)29.6817
2010's117 (31.28)24.3611
2020's41 (10.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.37 (24.57)
Research Supply Index5.65 (2.92)
Research Growth Index5.60 (4.65)
Search Engine Demand Index108.54 (26.88)
Search Engine Supply Index3.93 (0.95)

This Compound (38.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (2.16%)5.53%
Trials5 (4.59%)5.53%
Reviews6 (2.16%)6.00%
Reviews15 (13.76%)6.00%
Case Studies3 (1.08%)4.05%
Case Studies0 (0.00%)4.05%
Observational1 (0.36%)0.25%
Observational0 (0.00%)0.25%
Other262 (94.24%)84.16%
Other89 (81.65%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]